HUE057666T2 - Eljárás 4-metoxipirrol-származék köztiterméke elõállítására - Google Patents

Eljárás 4-metoxipirrol-származék köztiterméke elõállítására

Info

Publication number
HUE057666T2
HUE057666T2 HUE18821303A HUE18821303A HUE057666T2 HU E057666 T2 HUE057666 T2 HU E057666T2 HU E18821303 A HUE18821303 A HU E18821303A HU E18821303 A HUE18821303 A HU E18821303A HU E057666 T2 HUE057666 T2 HU E057666T2
Authority
HU
Hungary
Prior art keywords
preparation
intermediate product
methoxypyrrole derivative
methoxypyrrole
derivative
Prior art date
Application number
HUE18821303A
Other languages
English (en)
Hungarian (hu)
Inventor
Jeong-Taek Shin
Jeong Hyun Son
Seung Chul Lee
Original Assignee
Daewoong Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Pharmaceutical Co Ltd filed Critical Daewoong Pharmaceutical Co Ltd
Publication of HUE057666T2 publication Critical patent/HUE057666T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE18821303A 2017-06-21 2018-06-21 Eljárás 4-metoxipirrol-származék köztiterméke elõállítására HUE057666T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020170078745A KR102233455B1 (ko) 2017-06-21 2017-06-21 4-메톡시피롤 유도체의 중간체 제조 방법

Publications (1)

Publication Number Publication Date
HUE057666T2 true HUE057666T2 (hu) 2022-06-28

Family

ID=64735783

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE18821303A HUE057666T2 (hu) 2017-06-21 2018-06-21 Eljárás 4-metoxipirrol-származék köztiterméke elõállítására

Country Status (30)

Country Link
US (2) US11345660B2 (fr)
EP (1) EP3642181B1 (fr)
JP (1) JP6799178B2 (fr)
KR (1) KR102233455B1 (fr)
CN (1) CN110582482B (fr)
AU (1) AU2018288933B2 (fr)
CA (1) CA3061713C (fr)
CL (1) CL2019003450A1 (fr)
CO (1) CO2019012689A2 (fr)
DO (1) DOP2019000291A (fr)
EC (1) ECSP19081847A (fr)
ES (1) ES2901701T3 (fr)
HR (1) HRP20211819T1 (fr)
HU (1) HUE057666T2 (fr)
JO (1) JOP20190265B1 (fr)
MA (1) MA49472B1 (fr)
MX (1) MX391715B (fr)
MY (1) MY188800A (fr)
NZ (1) NZ758770A (fr)
PE (1) PE20210151A1 (fr)
PH (1) PH12019502865A1 (fr)
PL (1) PL3642181T3 (fr)
PT (1) PT3642181T (fr)
RS (1) RS62564B1 (fr)
RU (1) RU2737470C1 (fr)
SA (1) SA519410407B1 (fr)
SG (1) SG11201911164WA (fr)
SI (1) SI3642181T1 (fr)
TN (1) TN2019000301A1 (fr)
WO (1) WO2018236153A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102081920B1 (ko) 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
KR102233455B1 (ko) * 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
US10789690B2 (en) * 2018-03-07 2020-09-29 Adobe Inc. Masking non-public content
KR102126576B1 (ko) 2018-09-19 2020-06-24 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
CN109867617A (zh) * 2019-04-03 2019-06-11 南京格亚医药科技有限公司 一种4-甲氧基吡咯中间体的制备方法
CN112094219B (zh) * 2020-09-10 2022-08-05 广东莱佛士制药技术有限公司 一种制备钾离子竞争性阻滞剂中间体的方法
AU2022280595B2 (en) 2021-05-26 2024-11-14 Daewoong Pharmaceutical Co., Ltd. Medicine container comprising liquid pharmaceutical composition of 1-(5-(2,4-difluorophenyl)-1-((3- fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n-methylmethanamine
KR102938657B1 (ko) * 2023-02-15 2026-03-12 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법
CN117326961B (zh) * 2023-09-27 2024-05-03 安徽峆一药业股份有限公司 一种非苏拉赞中间体的绿色合成方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5622948A (en) 1994-12-01 1997-04-22 Syntex (U.S.A.) Inc. Pyrrole pyridazine and pyridazinone anti-inflammatory agents
JP5173192B2 (ja) 2004-09-30 2013-03-27 武田薬品工業株式会社 プロトンポンプ阻害薬
KR101115857B1 (ko) 2005-08-30 2012-04-12 다케다 야쿠힌 고교 가부시키가이샤 산 분비 억제제로서 1-헤테로시클릴술포닐, 2-아미노메틸,5-(헤테로-) 아릴 치환된 1-h-피롤 유도체
CA2675221C (fr) * 2007-02-02 2016-02-23 F. Hoffmann-La Roche Ag Nouvelles 2-aminooxazolines servant de ligands du taar1 pour des troubles du snc
US20110059940A1 (en) 2008-05-08 2011-03-10 Bristol- Myers Squibb Company 2-Aryl Glycinamide Derivatives
US8895558B2 (en) * 2008-10-02 2014-11-25 Green Cross Corporation Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders
KR101613245B1 (ko) * 2015-04-27 2016-04-18 주식회사 대웅제약 신규의 4-메톡시 피롤 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
WO2017164575A1 (fr) * 2016-03-25 2017-09-28 Daewoong Pharmaceutical Co.,Ltd. Nouveau sel d'addition d'acide de 1-(5-(2,4-difluorophényl)-1-((3-fluorophényl)sulfonyl)-4-méthoxy-1h-pyrrol-3-yl)-n-méthylméthanamine
KR20170113040A (ko) * 2016-03-25 2017-10-12 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민의 신규한 산부가염
KR102081920B1 (ko) * 2016-03-25 2020-02-26 주식회사 대웅제약 1-(5-(2,4-다이플루오로페닐)-1-((3-플루오로페닐)술포닐)-4-메톡시-1h-피롤-3-일)-n-메틸메탄아민 염의 신규한 결정형
KR102233456B1 (ko) * 2017-05-31 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
KR102233455B1 (ko) * 2017-06-21 2021-03-29 주식회사 대웅제약 4-메톡시피롤 유도체의 중간체 제조 방법
KR102126576B1 (ko) * 2018-09-19 2020-06-24 주식회사 대웅제약 4-메톡시 피롤 유도체의 제조 방법

Also Published As

Publication number Publication date
RU2737470C1 (ru) 2020-11-30
BR112019027323A2 (pt) 2020-07-28
ECSP19081847A (es) 2019-11-30
PH12019502865A1 (en) 2020-12-07
EP3642181A1 (fr) 2020-04-29
SI3642181T1 (sl) 2022-04-29
AU2018288933A1 (en) 2019-11-21
EP3642181B1 (fr) 2021-11-03
US11345660B2 (en) 2022-05-31
HRP20211819T1 (hr) 2022-03-04
KR20180138476A (ko) 2018-12-31
RS62564B1 (sr) 2021-12-31
NZ758770A (en) 2022-01-28
CL2019003450A1 (es) 2020-03-27
MA49472B1 (fr) 2022-01-31
SA519410407B1 (ar) 2022-06-14
JOP20190265B1 (ar) 2023-03-28
EP3642181A4 (fr) 2020-12-09
JOP20190265A1 (ar) 2019-11-12
PT3642181T (pt) 2021-12-20
TN2019000301A1 (en) 2021-05-07
WO2018236153A1 (fr) 2018-12-27
KR102233455B1 (ko) 2021-03-29
US20200181080A1 (en) 2020-06-11
MA49472A (fr) 2020-04-29
DOP2019000291A (es) 2019-12-15
MX391715B (es) 2025-03-21
AU2018288933B2 (en) 2020-12-10
CN110582482B (zh) 2022-10-11
CA3061713A1 (fr) 2018-12-27
CA3061713C (fr) 2021-10-12
US20220259146A1 (en) 2022-08-18
JP2020519680A (ja) 2020-07-02
SG11201911164WA (en) 2020-01-30
PE20210151A1 (es) 2021-01-26
JP6799178B2 (ja) 2020-12-09
CO2019012689A2 (es) 2020-01-17
MY188800A (en) 2022-01-04
ES2901701T3 (es) 2022-03-23
CN110582482A (zh) 2019-12-17
PL3642181T3 (pl) 2022-02-14

Similar Documents

Publication Publication Date Title
HUE059158T2 (hu) Eljárás pridopidin elõállítására
PL3426071T3 (pl) Wyrób do wytwarzania aerozolu
HUE053138T2 (hu) Eljárás bútortermékek lapjainak formázásához
SI3433285T1 (sl) Izboljšan postopek za pripravo sugamadeksa
IL264143B (en) Processes for preparing olaparib
HUE064612T2 (hu) Eljárás brivaracetam elõállítására
IL250525A0 (en) Process for preparing synthetic intermediates for preparing tetrahydroquinoline derivatives
IL267508B (en) A process for the preparation of 2-pyridylethyl carboxamide derivatives
LT3652491T (lt) Produkto liofilizavimo būdas
HUE050974T2 (hu) Eljárás pirimidinszulfamid-származékok elõállítására
HUE053171T2 (hu) Eljárás lapszerû dohányanyag gyártására
FI20155385A7 (fi) Menetelmät tuotteiden jatkuvaksi tuottamiseksi mikro-organismeista
IL260730B (en) Process for preparing terpinene-4-ol
HUE055463T2 (hu) Eljárás glükopiranozil-szubsztituált benzil-benzol-származékok elõállítására
HUE049606T2 (hu) Eljárás flavonoid inklúziós vegyületek elõállítására
HUE053818T2 (hu) Eljárás HMF elõállítására
HUE049170T2 (hu) Eljárás szubsztituált cikloszerinek elõállítására
IT201600105178A1 (it) Procedimento per la produzione di dieni
IL260465B (en) A process for preparing an antibody-rifamycin conjugate
HUE047756T2 (hu) Eljárás metil-merkaptán elõállítására
HUE045704T2 (hu) Eljárás 5-fluor-1H-pirazolok elõállítására hexafluorpropénbõl kiindulva
HUE064544T2 (hu) Eljárás kromatográfiai termékek összetételének beállítására
HUE055374T2 (hu) Eljárás Lenvatinib elõállítására
IL271388B (en) Improved process for preparing imetelstat
HUE064895T2 (hu) Eljárás palbociklib elõállítására